Back to results
US 6,310,057 B1Granted
α-ketoamide multicatalytic protease inhibitors
AssigneeCephalon, Inc.
InventorsSankar Chatterjee, John P. Mallamo
Life of this patent
Estimating the term…
Abstract
This invention relates to α-ketoamide inhibitors of multicatalytic protease (MCP), to compositions including such inhibitors, and to methods for the use of MCP inhibitors. The MCP inhibitors of the present invention are useful, for example, to retard loss of muscle mass incident to various physiological states.
Claims32
A compound having the Formula I:
- wherein:
- R1 is selected from the group consisting of —C—N, —C(═O)OR8, phthalimido, —NHSO2R8, and —NH—J;
- R2 is selected from the group consisting of H, hydroxyl, alkyl having from one to ten carbons and cycloalkyl having from three to seven carbons;
- R3 is selected from the group consisting of —(CH2)m—NHC(═N—R5)—NH2, —R6—H, —R6—J, —R12—(J)2, —R6—NO, —R—CN, —(CH2)m—NH2, and —(CH2)—NH—J;
- R4 is —CH(CH2R7)—Q;
- R5 is selected from the group consisting of -NO2, —CN, and —J;
- R6 is —(CH2)m—NH—C(═NH)—NH—;
- R12 is —(CH2)m—NH—C(═NH)—N—;
- Q is —C(═O)C(═O)NH—X—A—Y;
- R7 is selected from the group consisting of phenyl, and alkyl having from one to eight carbons, said alkyl group being optionally substituted with one or more halogen atoms, aryl, or heteroaryl groups;
- R8 is selected from the group consisting of hydrogen and alkyl having from one to six carbons, said alkyl group being optionally substituted with one or more halogen atoms, aryl or heteroaryl groups;
- X is a bond or —O—;
- A is an alkylene group of 1 to 8 carbons, said alkylene group being optionally substituted with one or more halogen atoms, aryl, or heteroaryl groups;
- Y is N(R13)—G;
- G is selected from the group consisting of H, a blocking group, SO2R9, —C(═O)NHR10, —C(═S)NHR10, and —CO2R9;
- or the moiety —A—Y forms a 5-, 6-, or 7-membered lactam ring;
- R9 is selected from the group consisting of alkyl, aryl, and heteroaryl, said alkyl, aryl, or heteroaryl groups being optionally substituted with K;
- R10 is selected from the group consisting of H, alkyl, aryl, and heteroaryl, said alkyl, aryl, or heteroaryl groups being optionally substituted with K;
- R13 is selected from the group consisting of H and lower alkyl;
- J is a blocking group;
- K is selected from the group consisting of halogen, CO2R10, R10OC(═O), R10OC(═O)NH, OH, CN, NO2, NR10R11, N═C(NR10R11)2, SR10, OR10, phenyl, naphthyl, heteroaryl, and a cycloalkyl group having from 3 to 8 carbon atoms;
- R11 is the same as R10;
- n is an integer from 5 to 10;
- m is an integer from 2 to 5;
- or a pharmaceutically acceptable salt thereof;
- with the proviso that when X is a bond and R3 is —R6—H or —(CH2)m—NH2, then G is SO2R9.
23 more elements
A composition for the reduction of Cu/Zn superoxide dismutase-1 enzyme degradation comprising an inhibitor of multicatalytic protease and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.